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Abstract
Background: Fat Embolism is a complication of long bone fractures, intramedullary fixation and
joint arthroplasty. It may progress to fat embolism syndrome, which is rare but involves significant
morbidity and can occasionally be fatal. Fat Embolism can be detected at the time of embolization
by transoesophageal echocardiography or atrial blood sampling. Later, a combination of clinical
signs and symptoms will point towards fat embolism but there is no specific test to confirm the
diagnosis. We investigated serum Interleukin-6 (IL-6) as a possible early marker for fat embolism.
Methods: An animal study was conducted to simulate a hip replacement in 31 adult male Sprague
Dawley rats. The procedure was performed under general anesthesia and the animals divided into
3 groups: control, uncemented and cemented. Following surgery and recovery from anaesthesia,
the rats allowed to freely mobilize in their cages. Blood was taken before surgery and at 6 hours,
12 hours and 24 hours to measure serum IL-6 levels. The rats were euthanized at 24 hours and
lungs removed and stained for fat. The amount of fat seen was then correlated with serum IL-6
levels.
Results: No rats in the control group had fat emboli. Numerous fat emboli were seen in both the
uncemented and cemented implant groups. The interleukin levels were raised in all groups reaching
a peak at 12 hours after surgery reaching 100 pg/ml in the control group and around 250 pg/ml in
the uncemented and cemented implant groups. The IL-6 levels in the control group were
significantly lower than any of the implant groups at 12 and 24 hours. At these time points, the
serum IL-6 correlated with the amount of fat seen on lung histology.
Conclusion: Serum IL-6 is a possible early marker of fat embolism.
Introduction
Fat embolism occurs when fat and marrow content from
bone gains access to the circulation and becomes trapped
in the capillaries of the lungs or other organs [1]. Bone
marrow in the long bones of mature adults contains up to
92% of fat [2]. The fat is released following skeletal
trauma [3,4] or from manipulation of the medullary canal
during hip and knee arthroplasty [5]. Fat emboli in the
lungs trigger an inflammatory process leading to hemor-
rhage and leakage of proteins into the alveoli [6].
Inflammatory mediators have also been implicated in the
lung changes following fat embolism [7,8] such as IL-6,
CD-11b expression, elastase and s-E-selectin [9]. One
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study showed that IL-6 and TNF-alpha were elevated in
cases of multiple fractures [8]. Syrbu concluded that fol-
lowing fat embolism broncho-alveolar lavage contained
inflammatory mediators [10].
IL-6 is one of the most important cytokine in the acute
inflammatory phase [11]. It is also one of the mediator
that is released very early in an injury process [12]. At the
moment, there is no specific blood test that can be used to
detect fat embolism. Diagnosis is mainly by clinical fea-
tures and supported by a few laboratory tests. This often
results in delayed treatment which can be detrimental to
the patient. Having a reliable marker for fat embolism
would be of great clinical benefit and the aim of our study
was to determine whether IL-6 was such a marker.
An animal model using Sprague Dawley rats was used for
this study. Many studies have utilized rats as a model for
fat embolism [13-17]. Most of them used external infu-
sion of fatty acids to simulate fat embolism. However
bone marrow cells are a significant part of the material
embolized and in order to reproduce the clinical situation
more closely we chose to embolize the animal's own med-
ullary content rather than injecting fatty acids. The medul-
lary cavity of Sprague Dawley rats has been shown to
contain around 5% of fat cells [18]. Our animal model for
fat embolism is described in the methodology section. It
has been shown that rats have a heart circulation that
closely resembles that of humans making them suitable to
study the effects of embolism on the cardio repiratory sys-
tem [19]. The rat animal model was chosen as it allowed
us to carry out a surgical procedure generating fat
embolislm, measure serum levels of IL-6 and provided
lung biopsy samples to confirm that embolism had actu-
ally occurred and also to quantify the amount of fat
deposited in the lungs. For those reasons the Sprague
Dawley rat was used as an animal model in this study.
The objective of this study was to assess whether the
serum concentration of an inflammatory marker could be
correlated to the extent of inflammation secondary from
fat embolism. The ultimate aim would be to use the
marker as an early diagnostic tool for a condition (FES)
notorious for late detection. Although there are many
inflammatory markers, we selected IL-6 as a marker for a
few reasons. Firstly the ELISA kit for measuring IL-6
required 0.5 mls of blood for each measurement. As
inflammatory cytokines are elevated in hemorrhagic
shock [20,21] we wanted to reduce the amount of blood
taken by limiting our study to IL-6. Removal of up to 7.5%
(1.5 mls in our 500 gm rats) of the total circulating blood
volume is considered to be safe [22] and in order to avoid
stressing the animals and falsely raising the inflammatory
cytokines we selected to study only one inflammatory
marker. Secondly, IL-6 is an inflammatory marker that is
activated in the early phase of the acute inflammatory
response and therefore would allow early detection and
treatment of fat embolism. Finally, we had to limit our-
selves to one marker as the rat model did not allow us to
draw enough blood to study multiple markers.
Procedure
Thirty one adult male Sprague Dawley rats were used.
They were divided into 3 groups: control (n = 9), unce-
mented implant (n = 10) and cemented implant (n = 12).
Prior approval from the institutional animal ethics com-
mittee was obtained. These rats were housed in standard
solid floor cages with wood shaving litter. The animals
were induced using inhalational halothane anesthesia
with a mixture of oxygen. Depth of anesthesia was
assessed by pedal reflex. After each animal was anaesthe-
tized, it was placed in a supine position and the skin over
both knee joints was shaved and disinfected. A skin inci-
sion was made over the flexed knee joint. A medial parap-
atella incision allowed retraction of the patella laterally,
exposing the distal femur.
There were 3 different groups:
i) Controls
A 2 mm drill perforated the articular cartilage at the supe-
rior end of the inter-condylar notch, taking great care not
to breach the medullary canal. The medial parapatella
wound was closed using Vicryl sutures and the skin with
staples. This was repeated on the contralateral side.
ii) uncemented implant group
This group had the same surgical approach as the controls.
However after breaching the articular cartilage, the 2 mm
drill was advanced well into the medullary canal. A 2 mm
Kirchner wire (2.5 cm long) was then advanced (Figure 1)
until it was flush with the joint surface. The wound was
closed in the same manner as the controls. This was
repeated on the contralateral side.
iii) cemented implant group
They had the identical approach as the uncemented
implant group up to the drilling of the medullary canal.
Then, a freshly mixed bone cement (CMW 1, DePuy Inter-
national Ltd, England) was pressurized into the canal
using a syringe and modified needle (Figure 2). A 2 mm
Kirchner wire (2.5 cm long) then advanced into the canal
until it was flush with the joint surface. The extruded
cement was removed. The wound was closed in the same
manner as the controls. This was repeated on the contral-
ateral side.
The same surgeon performed all surgery. The three groups
were alternated sequentially until all the rats were oper-
ated. Blood (0.5 mls) was taken from a tail vein beforeJournal of Orthopaedic Surgery and Research 2009, 4:18 http://www.josr-online.com/content/4/1/18
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surgery, at 6 hours and at 12 hours while the animals were
briefly anaesthetised. At 24 hours, all the rats were eutha-
nized. Intracardiac blood was then taken immediately
after death. A midline chest incision was made to expose
the lungs and heart. The trachea was transected and the
lungs expanded using formalin saline injected via the cut
trachea. The right upper lobe and the left lobe were proc-
essed for histological examination. Osmium Tetroxide
was used to stain fat within the tissues [23,24]. The lungs
were wax-impregnated and sectioned. Finally they were
counterstained with Haematoxilin and Eosin.
Slides were viewed using light microscopy with a help of
a pathologist. In order not to under or over estimate the
amount of embolised material, all fat globules seen in the
slide were counted at 10× magnification. Subsequently,
the surface area for the lung section was estimated using a
10 mm by 10 mm square grid (the grid was made up of 1
mm2 boxes). The crossectional areas of the right upper
lobe and the left lobs sections were determined. The den-
sity of fat emboli per 100 mm2 was then calculated.
The blood collected was initially centrifuged at 4000 rev-
olutions per minute for 4 minutes. The serum was then
isolated and stored in a minus 80 degrees fridge until all
the samples had been collected. On the day of ELISA anal-
ysis, the samples were thawed to room temperature. The
serum was then processed following the recommenda-
tions of the IL-6 kit manufacturer (R&D Systems).
All the reagents (which were stored at minus 20 degrees
Celsius) were brought to room temperature. The 96 well
ELISA plate was filled with 50 μl of assay diluents in each
well. Each sample was processed in duplicate with the
final result calculated as the mean of both values. The first
2 rows (8 wells in each row) were filled up with 50 μl of
either the standard or control samples. There were 7
standards of known IL-6 values, which ranged from the
lowest to the highest measurable IL-6 concentration that
was provided by the manufacturer (62.5 pg/l to 4000 pg/
l) and the control was a single sample of known concen-
tration (given by the manufacturer) that was used to
ensure quality control. The subsequent 10 rows were filled
with 50 μl of test serum to each well and these too were
processed in duplicate. All plates were incubated for 2
hours. They were then aspirated and washed 5 times using
a plate washer. Subsequently 100 μl of conjugate was
added to each well and incubated for 2 hours. It was then
aspirated and washed with a buffer solution 5 times.
Finally 100 μl of substrate solution was added and pro-
tected from light for 30 minutes. Then 100 μl of stop solu-
tion was applied to each well. The optical density was then
read at 450 nm on an Omron spectrophotometer. The
reading was printed out and the duplicates averaged out.
A standard curve was drawn using the values obtained
from the 7 standards. The control sample ensured that the
quality readings obtained was within the set limits.
Finally, the values for the test samples were worked out
from the standard curve.
We postulated that more extensive fat embolism occurred
in the uncemented and cemented implant groups. We
Kirschner wire being advanced into the femoral canal Figure 1
Kirschner wire being advanced into the femoral 
canal.
Cement being injected into the medullary canal using a  syringe Figure 2
Cement being injected into the medullary canal using 
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used the Analysis of Variance (ANOVA) to see if there
were any statistical differences between the three groups
with regards to the amount of fat. Subsequently, we
applied Fisher's Least Significant Difference (LSD) as a
post hoc test to study if there were any differences between
these three groups. We used p < 0.05 as the confidence
interval. We also postulated that the IL-6 levels would be
higher if there was more fat embolism seen, therefore a
comparison was calculated with the IL-6 levels at the var-
ious time points. ANOVA was used with LSD as a post hoc
procedure to see if there was any difference in the 3 groups
studied in the four different time points.
Finally, we wanted to see if we could correlate the fat
embolism to the measured IL-6 levels. For this, we ini-
tially combined all the three different groups and com-
pared the IL-6 levels at the three different time points (6
hours, 12 hours and 24 hours) with the amount of fat
embolism seen. Correlation of the number of fat emboli
and IL-6 levels at 6 hours, 12 hours and 24 hours irrespec-
tive of the three groups was carried out using the Spear-
mans Rank Correlation test. This test gives a Spearman
Correlation Coefficient between -1 and +1. A value closer
to +1 will indicate a direct positive correlation. All the
tests completed were using the Statistical Package for
Social Sciences (SPSS) Version 11 for Windows.
Results
Out of the 31 rats in this study 3 rats died during surgery.
All of them belonged to the cemented implant group and
they were excluded from the study.
Figure 3 shows the fat emboli density in the 3 different
groups. There were no emboli seen in the control group.
Both the uncemented (p < 0.034) and cemented implant
groups (p < 0.001) had a significantly higher number of
fat emboli compared to the control group. There were also
a significantly higher number of emboli (p < 0.040) in the
cemented compared to the uncemented implant group. In
the slides where there was fat embolism, there was a clear
aggregation of inflammatory cells and hemorrhage in the
alveoli (Figure 4).
The IL-6 levels were raised in the three groups reaching a
peak at 12 hours after surgery (Figure 5). At this time
point, levels had risen by a 100 pg/ml for the control and
around 250 pg/ml for the implant groups. Subsequently,
all three groups demonstrated a fall in IL-6 levels up to 24
hours. There were significant changes between the groups
at 12 hours (p < 0.049) and at 24 hours (P < 0.025). The
IL-6 levels in the control group were significantly lower
than in the uncemented implant group at 12 hours (p <
0.046) and 24 hours (p < 0.025). IL-6 levels in the control
group were also significantly lower at 12 hours (p <
0.024) and 24 hours (p < 0.013) compared to the
cemented implant group. There was no significant differ-
ence in the IL-6 levels between the uncemented and
cemented implant group at all time points. Although the
IL-6 levels dropped after 12 hours in all 3 groups, it did
not reach the pre operative levels at 24 hours.
From the results above, it is clear that the surgical
approach to the femur or anesthesia or both had a part to
play in the rise of IL-6. In an attempt to remove this influ-
ence, we subtracted the IL-6 levels measured in the control
Fat emboli seen in the 3 different groups Figure 3
Fat emboli seen in the 3 different groups.
Presence of fat (stained black) in the lungs of the rat Figure 4
Presence of fat (stained black) in the lungs of the rat. 
There are numerous inflammatory cells and red blood cells 
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group from the levels measured in the implant groups for
all respective time points. This gave an estimation of Il-6
rise without the influence of surgical approach or anesthe-
sia. Figure 6 shows that there is still a peak at 12 hours.
The most likely cause of the raised IL-6 levels in the
implant groups is fat embolism as the only difference
between them and the control group was the fat seen on
lung histology. The correlation coefficient at 6 hours
between IL-6 and the number of emboli seen was 0.292.
At 12 and 24 hours the correlation coefficient was 0.494
and 0.405 respectively. This indicates that there was a pos-
itive correlation between fat embolism and IL-6. This cor-
relation was stronger at 12 and 24 hours.
Discussion
The receptor for IL-6 is found on many cell surfaces
including resting normal T-cells, activated normal B-cells,
myeloid cell lines and others. IL-6 stimulates acute phase
reaction that is responsible for fever, increased erythrocyte
sedimentation rate and activation of clotting cascades, all
of which are seen in established fat embolism syndrome.
IL-6 is sensitive to tissue damage [25] and local levels of
IL-6 may be higher than systemic levels [26-29]. In our
study only systemic levels of IL-6 were measured and they
could be an overspill of the local IL-6 [29] and we there-
fore assumed that systemic IL-6 levels correlate with local
IL-6 levels. Inflammation in the lungs probably is thought
to be due to the toxic effects of the free fatty acids released
from the breakdown of fat. Histology of the lungs in this
study confirmed the presence of inflammation at the time
of death. (Figure 3).
One study claimed that the inflammatory changes in the
lungs were immune mediated [7] whereas another con-
cluded that fat emboli are not the only cause of FES [30].
It is interesting that although fat embolism will occur in
almost all cases of long bone fractures, only a few cases
will develop fat embolism syndrome. One possible expla-
nation is the production of inflammatory mediators. Evi-
dence has shown that IL-6 is also responsible for adipose
tissue metabolism, lipoprotein lipase activity and hepatic
triglyceride secretion [31]. There is a polymorphism of the
IL-6 gene that will result in abnormalities in IL-6 tran-
scription rate. Experimental studies in humans comparing
the activity of this gene have shown that patients with pol-
ymorphism of the IL-6 gene are prone to lipid abnormal-
ities [32]. Although this was not demonstrated by these
authors, this abnormal IL-6 transcription could well lead
to an abnormal reaction to fat emboli in the lungs and the
development of a full blown fat embolism syndrome.
Various types of orthopaedic operations lead to an
increase in IL-6 serum levels [28,33]. This explains why in
the present study there was a rise in IL-6 levels in all 3
groups as the surgery involved some degree of muscle
injury to get access to the knee joint. However, although
the surgical approach was the same in the 3 groups, the
variation in IL-6 was significantly different and we have
shown that fat embolism demonstrated histologically
must be a major factor.
Serum Interleukin-6 levels plotted at 4 different time points Figure 5
Serum Interleukin-6 levels plotted at 4 different time 
points.
Serum IL-6 values against time between the cemented and  uncemented group after values from the control group were  subtracted from the corresponding values Figure 6
Serum IL-6 values against time between the 
cemented and uncemented group after values from 
the control group were subtracted from the corre-
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There was significant variability in IL-6 levels post surgery
within each group of animals. This variability has also
been shown by Minetto in his study if IL-6 levels after hip
surgery [34]. It is possible that different individuals
release different quantities of IL-6 when presented with
the same stimuli. Apart from that, he noted that the
upward slope of the IL-6 curve was related to the duration
of surgery. He also found that higher IL-6 levels were asso-
ciated with higher postoperative fever but without evi-
dence of differences in postoperative problems, time to
mobilize, or duration of stay in hospital. Postoperative
infection was also associated with higher IL-6 levels [35].
In our study, all animals were operated on in a small ani-
mal operating theatre using clean surgical techniques. The
surgical time varied between 10 to 15 minutes and the
same surgical protocol was used in all cases by one single
operator.
Inflammatory cells are responsible for the release of IL-6.
If it was released solely as a result of tissue trauma, it
should have increased straight after surgery and peaked at
6 hours. However in our study the peak was at 12 hours
that makes tissue trauma from the surgical procedure
unlikely. We have shown that release of IL-6 was due to fat
embolism and secondary lung tissue damage. This effect
was noted up to 24 hours. It is likely that emboli in the
lung trigger an inflammatory reaction, which takes time to
become established before IL-6 levels increase. This may
explain why there was no correlation between IL-6 rise
and the amount of fat emboli at 6 hours.
The significant correlation shown at 12 hours and 24
hours demonstrates that IL-6 rise is related to fat embo-
lism. In this study, the correlation was 0.494 and 0.405 at
12 and 24 hours respectively
This is an animal model and although we tried to repro-
duce a surgical procedure as closely as possible, the find-
ings cannot be automatically transferred to clinical
practice. IL-6 is only one of the inflammatory markers and
there are surely others involved in the pathogenesis of fat
embolism.
We have shown, using an animal fat embolism model,
that there are lung changes which correlate with IL-6
serum levels which makes us believe that IL-6 may be one
of the early markers of fat embolism. Further research is
required to validate the use of IL-6 as a reliable marker to
detect fat embolism in a clinical setting.
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